Life medicinePub Date : 2026-04-17eCollection Date: 2026-04-01DOI: 10.1093/lifemedi/lnag010
Weiyi Zhang, Chunyan Le, Shanru Yi, Wenqiang Liu, Xiaoyu Liu, Zhen Yin, Hong Wang, Rui Gao, Shaorong Gao, Jiayu Chen
{"title":"Single-cell analysis reveals essential lncRNAs regulating human trophoblast lineage differentiation.","authors":"Weiyi Zhang, Chunyan Le, Shanru Yi, Wenqiang Liu, Xiaoyu Liu, Zhen Yin, Hong Wang, Rui Gao, Shaorong Gao, Jiayu Chen","doi":"10.1093/lifemedi/lnag010","DOIUrl":"https://doi.org/10.1093/lifemedi/lnag010","url":null,"abstract":"<p><p>The human placenta sustains pregnancy through intricate trophoblast lineage dynamics that are critical for fetal development and pregnancy success. While studies on protein-coding genes (PCGs) have advanced our understanding of placental biology, the regulatory roles of noncoding RNAs, particularly long noncoding RNAs (lncRNAs), in trophoblast lineage specification and function remain poorly understood. Here, we profile single-cell lncRNA dynamics across human placental development, revealing distinct cell-type- and gestational stage-specific expression profiles. Integrated analysis revealed that lncRNAs modulate histone modification levels at the regulatory regions of target genes via <i>cis</i>-action, thereby regulating the expression of key genes essential for trophoblast differentiation. Functional studies by using <i>in vivo</i> and <i>in vitro</i> models fully identify <i>ECEL1P2</i>-<i>ALPP, SEMA3B-AS1</i>-<i>SEMA3B</i>, and <i>MYCNUT</i>/<i>MYCNOS</i>-<i>MYCN</i> as pivotal regulatory axes driving cytotrophoblast self-renewal, syncytiotrophoblast fusion, and epithelial-mesenchymal transition, respectively, which are essential for trophoblast identity and function. Notably, dysregulation of lncRNA-PCG pairs in pathological pregnancies underscores the clinical relevance of these noncoding networks. Together, our findings uncover an unappreciated layer of lineage-specific noncoding regulation, providing mechanistic insight and potential biomarkers for placental development and associated disorders.</p>","PeriodicalId":74073,"journal":{"name":"Life medicine","volume":"5 2","pages":"lnag010"},"PeriodicalIF":6.0,"publicationDate":"2026-04-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13117612/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147791225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Life medicinePub Date : 2026-04-09eCollection Date: 2026-04-01DOI: 10.1093/lifemedi/lnag009
Eman A Makhlouf, Riham A El-Shiekh, Mona M Okba, Hossam M Ashour
{"title":"Natural compounds of medicinal plants as a source for novel anti-orthopoxvirus medications.","authors":"Eman A Makhlouf, Riham A El-Shiekh, Mona M Okba, Hossam M Ashour","doi":"10.1093/lifemedi/lnag009","DOIUrl":"https://doi.org/10.1093/lifemedi/lnag009","url":null,"abstract":"","PeriodicalId":74073,"journal":{"name":"Life medicine","volume":"5 2","pages":"lnag009"},"PeriodicalIF":6.0,"publicationDate":"2026-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13109095/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147791193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Life medicinePub Date : 2026-04-07eCollection Date: 2026-04-01DOI: 10.1093/lifemedi/lnag012
Rosamaria Capuano, Carla Petrella, Christian Barbato, Giulia D'Arcangelo, Giusy Russo, Alexandro Catini, Antonio Minni, Corrado Di Natale, Salvatore Oliva
{"title":"Salivary volatilome profiling in pediatric eosinophilic esophagitis: a pilot study on a non-invasive approach in clinical practice.","authors":"Rosamaria Capuano, Carla Petrella, Christian Barbato, Giulia D'Arcangelo, Giusy Russo, Alexandro Catini, Antonio Minni, Corrado Di Natale, Salvatore Oliva","doi":"10.1093/lifemedi/lnag012","DOIUrl":"https://doi.org/10.1093/lifemedi/lnag012","url":null,"abstract":"<p><p>Eosinophilic esophagitis (EoE) is a chronic immune disease requiring repeated endoscopies for diagnosis and monitoring in children. Saliva represents a promising non-invasive biofluid, and volatile organic compounds (VOCs) may indicate disease presence and activity. This study aimed to examine the VOCs profile in saliva samples from children with EoE and to compare it with other gastrointestinal (GI) conditions and healthy controls. Thirty-five samples from children with EoE (including 13 active and 22 non-active cases), 19 from children with other GI conditions, and 46 from healthy controls were analyzed. Gas chromatography-ion mobility spectrometry (GC-IMS) identified 63 distinct VOC signal areas. The abundance of 16 of them was found significantly different (<i>P </i>< 0.01) in EoE vs. controls, EoE vs. other GI conditions, and active vs. non-active EoE. Among them, <i>cis</i>-3-hexen-1-ol and 2-phenylethanol show a ubiquitous capability to discriminate EoE against different populations. Linear discriminant analysis (LDA) of the panel of 16 VOCs achieved 83.3% accuracy in classifying EoE vs. healthy controls, 81.2% accuracy in distinguishing EoE from GI controls, and 80.0% accuracy in classifying active vs. non-active EoE. Salivary VOC profiling enables accurate discrimination of pediatric EoE from controls and stratification by disease activity. This non-invasive approach holds promise as a diagnostic and monitoring tool in clinical practice, especially in children.</p>","PeriodicalId":74073,"journal":{"name":"Life medicine","volume":"5 2","pages":"lnag012"},"PeriodicalIF":6.0,"publicationDate":"2026-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13148378/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147847064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Life medicinePub Date : 2026-03-27eCollection Date: 2026-04-01DOI: 10.1093/lifemedi/lnag011
Na Yu, Wenqiu Cai, Congyi Zhang, Qiyue Cai, Zisong Zhang, Yuqing Hu, Yan Sun, Kaiyao Yin, Feng Ren, KangXin Chang, MeiLing Jin, Dongxia Li, Liwen Zhang, Heming Wu, Mengwei Li
{"title":"The multistep progression of areca nut-induced oral cancer: a mechanistic roadmap from pathogenesis to precision therapy.","authors":"Na Yu, Wenqiu Cai, Congyi Zhang, Qiyue Cai, Zisong Zhang, Yuqing Hu, Yan Sun, Kaiyao Yin, Feng Ren, KangXin Chang, MeiLing Jin, Dongxia Li, Liwen Zhang, Heming Wu, Mengwei Li","doi":"10.1093/lifemedi/lnag011","DOIUrl":"https://doi.org/10.1093/lifemedi/lnag011","url":null,"abstract":"<p><p>Areca nut is classified as a Group 1 carcinogen by the International Agency for Research on Cancer. It is a widely consumed psychoactive substance with profound cultural roots in regions including Hunan, Hainan, and Taiwan of China. Its key bioactive components include alkaloids (e.g. arecoline and arecaidine) and areca nut-specific nitrosamines, that induce DNA damage, reactive oxygen species bursts, and chronic inflammation in oral tissues. Coupled with mechanical trauma from chewing, these insults drive the malignant progression of oral submucous fibrosis to oral cavity carcinomas. This review systematically outlines the pathological progression from normal oral mucosa to invasive oral cavity carcinomas, highlighting two core mediators of oral submucous fibrosis carcinogenesis: immune microenvironment reprogramming and oncogenic signaling activation. Furthermore, this review elaborates the molecular mechanisms of areca nut-induced oral cancer, providing a theoretical foundation for biomarker discovery and the development of novel therapeutic strategies. It also provides actionable guidance for reducing the incidence of areca nut-related oral cavity carcinomas and improving patient prognosis.</p>","PeriodicalId":74073,"journal":{"name":"Life medicine","volume":"5 2","pages":"lnag011"},"PeriodicalIF":6.0,"publicationDate":"2026-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13148401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147847058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Histidine phosphorylation of NME1 regulates the Hippo pathway via the ARHGAP17-CDC42-cytoskeleton axis.","authors":"Xian Liu, Zhongnan Chen, Jianxi Zhu, Shengcheng Deng, Zhifen Zhou, Wenbin Ma, Zhou Songyang","doi":"10.1093/lifemedi/lnag002","DOIUrl":"https://doi.org/10.1093/lifemedi/lnag002","url":null,"abstract":"<p><p><b>NME1 is a key metastasis suppressor whose activity depends on histidine phosphorylation, yet the biological significance of this modification remains poorly understood. Here, we reveal a previously unrecognized role for NME1 in regulating the Hippo pathway. Using PhastID-based proximity labeling combined with functional assays, we demonstrate that NME1 modulates CDC42 activity via ARHGAP17, a GTPase-activating protein, thereby influencing cytoskeletal organization and Hippo activation. Loss of NME1 reduced YAP phosphorylation and promoted its nuclear localization, indicating suppression of Hippo signaling. These findings define a histidine phosphorylation-dependent NME1-ARHGAP17-CDC42-cytoskeleton axis that controls the Hippo pathway, providing new insights into the functional repertoire of NME1 in cancer and development</b>.</p>","PeriodicalId":74073,"journal":{"name":"Life medicine","volume":"5 1","pages":"lnag002"},"PeriodicalIF":6.0,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13070683/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147679355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Life medicinePub Date : 2026-02-19eCollection Date: 2026-02-01DOI: 10.1093/lifemedi/lnaf039
Zeyu Gao, Mei Li, Jingyi Li, Moshi Song
{"title":"New paradigm for aging research: aging studies through innovative AI applications and interdisciplinary collaborations.","authors":"Zeyu Gao, Mei Li, Jingyi Li, Moshi Song","doi":"10.1093/lifemedi/lnaf039","DOIUrl":"10.1093/lifemedi/lnaf039","url":null,"abstract":"","PeriodicalId":74073,"journal":{"name":"Life medicine","volume":"5 1","pages":"lnaf039"},"PeriodicalIF":6.0,"publicationDate":"2026-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12948406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147328333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"iPSC-derived breast cancer models: advancing the study of <i>BRCA1</i>-driven tumorigenesis.","authors":"Pengguihang Zeng, Zhuheng Zhang, Xinyi Liu, Junjun Ding","doi":"10.1093/lifemedi/lnag006","DOIUrl":"https://doi.org/10.1093/lifemedi/lnag006","url":null,"abstract":"","PeriodicalId":74073,"journal":{"name":"Life medicine","volume":"5 2","pages":"lnag006"},"PeriodicalIF":6.0,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13109093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147791230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}